Prystowsky, M., Feeney, K., Kawachi, N., Montagna, C., Willmott, M., Wasson, C., Antkowiak, M., Loudig, O. and Parish, J. (2013) Inhibition of Plk1 and Cyclin B1 Expression Results in Panobinostat-
Induced G2 Delay and Mitotic Defects. Scientific Reports, 3, 2640. http://dx.doi.org/10.1038/srep026
40

has been cited by the following article:

• TITLE: Missing the Target?—Targeted Therapy in Small Cell Lung Cancer

  AUTHORS: Karin R. Purshouse

  KEYWORDS: Oncology, Small Cell Lung Cancer, Targeted Therapy, Drug Development

  JOURNAL NAME: Advances in Lung Cancer, Vol.3 No.3, August 22, 2014

  ABSTRACT: Small cell lung cancer [SCLC] is a devastating form of cancer, with most patients harbouring extensive disease at diagnosis and survival of less than 5% at five years. Progress in novel therapies has been limited. This specialist review explores current targeted therapy options and potential areas of development.